nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—ALB—melanoma	0.538	1	CbGaD
Cefazolin—ALB—Vemurafenib—melanoma	0.0898	1	CbGbCtD
Cefazolin—PON1—blood vessel—melanoma	0.0173	0.398	CbGeAlD
Cefazolin—SLC22A8—optic choroid—melanoma	0.0083	0.191	CbGeAlD
Cefazolin—Induration—Bleomycin—melanoma	0.00601	0.026	CcSEcCtD
Cefazolin—Cheilitis—Dactinomycin—melanoma	0.00589	0.0255	CcSEcCtD
Cefazolin—PON1—head—melanoma	0.00523	0.12	CbGeAlD
Cefazolin—Local reaction—Bleomycin—melanoma	0.00485	0.021	CcSEcCtD
Cefazolin—Nephropathy toxic—Bleomycin—melanoma	0.00468	0.0203	CcSEcCtD
Cefazolin—Drug fever—Docetaxel—melanoma	0.00451	0.0196	CcSEcCtD
Cefazolin—Nephropathy toxic—Carmustine—melanoma	0.00408	0.0177	CcSEcCtD
Cefazolin—Oral candidiasis—Carmustine—melanoma	0.00369	0.016	CcSEcCtD
Cefazolin—Oral candidiasis—Temozolomide—melanoma	0.00357	0.0155	CcSEcCtD
Cefazolin—Cholestasis—Temozolomide—melanoma	0.00298	0.0129	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.0029	0.0126	CcSEcCtD
Cefazolin—TPMT—retina—melanoma	0.00278	0.0639	CbGeAlD
Cefazolin—Eosinophilia—Vemurafenib—melanoma	0.00275	0.0119	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00246	0.0107	CcSEcCtD
Cefazolin—Oral candidiasis—Docetaxel—melanoma	0.00237	0.0103	CcSEcCtD
Cefazolin—Aplastic anaemia—Dactinomycin—melanoma	0.00235	0.0102	CcSEcCtD
Cefazolin—Vaginal inflammation—Temozolomide—melanoma	0.00227	0.00982	CcSEcCtD
Cefazolin—Mouth ulceration—Dactinomycin—melanoma	0.00227	0.00982	CcSEcCtD
Cefazolin—Phlebitis—Bleomycin—melanoma	0.00226	0.00981	CcSEcCtD
Cefazolin—Candida infection—Carmustine—melanoma	0.00224	0.0097	CcSEcCtD
Cefazolin—TPMT—mammalian vulva—melanoma	0.00222	0.0511	CbGeAlD
Cefazolin—Liver disorder—Docetaxel—melanoma	0.00221	0.00958	CcSEcCtD
Cefazolin—Cefmetazole—SLC15A2—melanoma	0.00219	0.139	CrCbGaD
Cefazolin—Heartburn—Docetaxel—melanoma	0.00219	0.00949	CcSEcCtD
Cefazolin—Candida infection—Temozolomide—melanoma	0.00216	0.00938	CcSEcCtD
Cefazolin—Vaginal infection—Temozolomide—melanoma	0.00214	0.00927	CcSEcCtD
Cefazolin—Aplastic anaemia—Temozolomide—melanoma	0.00213	0.00922	CcSEcCtD
Cefazolin—Phlebitis—Dactinomycin—melanoma	0.00211	0.00915	CcSEcCtD
Cefazolin—Erythema multiforme—Vemurafenib—melanoma	0.00211	0.00912	CcSEcCtD
Cefazolin—Phlebitis—Carmustine—melanoma	0.00198	0.00856	CcSEcCtD
Cefazolin—Cefuroxime—SLC15A2—melanoma	0.00186	0.118	CrCbGaD
Cefazolin—SLC22A8—eye—melanoma	0.00167	0.0384	CbGeAlD
Cefazolin—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00164	0.0071	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00164	0.0071	CcSEcCtD
Cefazolin—Pancytopenia—Bleomycin—melanoma	0.0016	0.00694	CcSEcCtD
Cefazolin—Blood bilirubin increased—Docetaxel—melanoma	0.00159	0.0069	CcSEcCtD
Cefazolin—TPMT—head—melanoma	0.00159	0.0366	CbGeAlD
Cefazolin—Anaphylactic shock—Vemurafenib—melanoma	0.00158	0.00686	CcSEcCtD
Cefazolin—Pancytopenia—Dactinomycin—melanoma	0.00149	0.00647	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00148	0.00642	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00148	0.00642	CcSEcCtD
Cefazolin—Cefdinir—SLC15A2—melanoma	0.00148	0.0938	CrCbGaD
Cefazolin—Hypotension—Vemurafenib—melanoma	0.00148	0.00641	CcSEcCtD
Cefazolin—Neutropenia—Dactinomycin—melanoma	0.00147	0.00637	CcSEcCtD
Cefazolin—Stomatitis—Bleomycin—melanoma	0.00146	0.00635	CcSEcCtD
Cefazolin—Colitis—Docetaxel—melanoma	0.00145	0.00627	CcSEcCtD
Cefazolin—Candida infection—Docetaxel—melanoma	0.00144	0.00623	CcSEcCtD
Cefazolin—Cefradine—SLC15A2—melanoma	0.00141	0.0891	CrCbGaD
Cefazolin—Pancytopenia—Carmustine—melanoma	0.0014	0.00605	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00139	0.00602	CcSEcCtD
Cefazolin—Neutropenia—Carmustine—melanoma	0.00138	0.00596	CcSEcCtD
Cefazolin—Decreased appetite—Vemurafenib—melanoma	0.00138	0.00596	CcSEcCtD
Cefazolin—Stomatitis—Dactinomycin—melanoma	0.00137	0.00592	CcSEcCtD
Cefazolin—Fatigue—Vemurafenib—melanoma	0.00136	0.00591	CcSEcCtD
Cefazolin—Haemoglobin—Bleomycin—melanoma	0.00136	0.00588	CcSEcCtD
Cefazolin—Pancytopenia—Temozolomide—melanoma	0.00135	0.00585	CcSEcCtD
Cefazolin—Haemorrhage—Bleomycin—melanoma	0.00135	0.00585	CcSEcCtD
Cefazolin—Lightheadedness—Docetaxel—melanoma	0.00135	0.00584	CcSEcCtD
Cefazolin—Cefadroxil—SLC15A2—melanoma	0.00133	0.0843	CrCbGaD
Cefazolin—Neutropenia—Temozolomide—melanoma	0.00133	0.00576	CcSEcCtD
Cefazolin—Agranulocytosis—Dactinomycin—melanoma	0.00131	0.00567	CcSEcCtD
Cefazolin—Renal failure—Carmustine—melanoma	0.00129	0.00559	CcSEcCtD
Cefazolin—Stomatitis—Carmustine—melanoma	0.00128	0.00554	CcSEcCtD
Cefazolin—Phlebitis—Docetaxel—melanoma	0.00127	0.0055	CcSEcCtD
Cefazolin—Hepatitis—Dactinomycin—melanoma	0.00126	0.00545	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00126	0.00545	CcSEcCtD
Cefazolin—Body temperature increased—Vemurafenib—melanoma	0.00125	0.00542	CcSEcCtD
Cefazolin—Stomatitis—Temozolomide—melanoma	0.00124	0.00535	CcSEcCtD
Cefazolin—Erythema multiforme—Dactinomycin—melanoma	0.00119	0.00516	CcSEcCtD
Cefazolin—Haemoglobin—Carmustine—melanoma	0.00118	0.00513	CcSEcCtD
Cefazolin—Haemorrhage—Carmustine—melanoma	0.00118	0.0051	CcSEcCtD
Cefazolin—Hypersensitivity—Vemurafenib—melanoma	0.00117	0.00505	CcSEcCtD
Cefazolin—Cefotaxime—SLC15A2—melanoma	0.00116	0.0735	CrCbGaD
Cefazolin—Haemoglobin—Temozolomide—melanoma	0.00114	0.00496	CcSEcCtD
Cefazolin—Ceftriaxone—SLC15A2—melanoma	0.00114	0.0724	CrCbGaD
Cefazolin—Haemorrhage—Temozolomide—melanoma	0.00114	0.00493	CcSEcCtD
Cefazolin—Hepatitis—Temozolomide—melanoma	0.00114	0.00493	CcSEcCtD
Cefazolin—Asthenia—Vemurafenib—melanoma	0.00113	0.00492	CcSEcCtD
Cefazolin—Pruritus—Vemurafenib—melanoma	0.00112	0.00485	CcSEcCtD
Cefazolin—TPMT—lymph node—melanoma	0.00111	0.0256	CbGeAlD
Cefazolin—Anaemia—Bleomycin—melanoma	0.00109	0.0047	CcSEcCtD
Cefazolin—Diarrhoea—Vemurafenib—melanoma	0.00108	0.00469	CcSEcCtD
Cefazolin—Erythema multiforme—Temozolomide—melanoma	0.00108	0.00466	CcSEcCtD
Cefazolin—Leukopenia—Bleomycin—melanoma	0.00105	0.00456	CcSEcCtD
Cefazolin—Dizziness—Vemurafenib—melanoma	0.00105	0.00453	CcSEcCtD
Cefazolin—Anaemia—Dactinomycin—melanoma	0.00101	0.00439	CcSEcCtD
Cefazolin—Vomiting—Vemurafenib—melanoma	0.00101	0.00436	CcSEcCtD
Cefazolin—Cefalotin—SLC15A2—melanoma	0.001	0.0634	CrCbGaD
Cefazolin—Abdominal pain upper—Docetaxel—melanoma	0.000999	0.00433	CcSEcCtD
Cefazolin—Rash—Vemurafenib—melanoma	0.000997	0.00432	CcSEcCtD
Cefazolin—Dermatitis—Vemurafenib—melanoma	0.000996	0.00432	CcSEcCtD
Cefazolin—Headache—Vemurafenib—melanoma	0.000991	0.00429	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000985	0.00427	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000985	0.00427	CcSEcCtD
Cefazolin—Leukopenia—Dactinomycin—melanoma	0.00098	0.00425	CcSEcCtD
Cefazolin—Confusional state—Bleomycin—melanoma	0.000966	0.00419	CcSEcCtD
Cefazolin—Anaphylactic shock—Bleomycin—melanoma	0.000958	0.00415	CcSEcCtD
Cefazolin—ABCC4—head—melanoma	0.000956	0.022	CbGeAlD
Cefazolin—SLC22A8—head—melanoma	0.000948	0.0218	CbGeAlD
Cefazolin—Anaemia—Carmustine—melanoma	0.000947	0.00411	CcSEcCtD
Cefazolin—Agitation—Carmustine—melanoma	0.000942	0.00408	CcSEcCtD
Cefazolin—Nausea—Vemurafenib—melanoma	0.00094	0.00407	CcSEcCtD
Cefazolin—Thrombocytopenia—Bleomycin—melanoma	0.000938	0.00407	CcSEcCtD
Cefazolin—Leukopenia—Carmustine—melanoma	0.000918	0.00398	CcSEcCtD
Cefazolin—Anaemia—Temozolomide—melanoma	0.000916	0.00397	CcSEcCtD
Cefazolin—Anorexia—Bleomycin—melanoma	0.000914	0.00396	CcSEcCtD
Cefazolin—Agitation—Temozolomide—melanoma	0.00091	0.00395	CcSEcCtD
Cefazolin—Cephalexin—SLC15A2—melanoma	0.00091	0.0577	CrCbGaD
Cefazolin—Pancytopenia—Docetaxel—melanoma	0.000898	0.00389	CcSEcCtD
Cefazolin—Hypotension—Bleomycin—melanoma	0.000896	0.00388	CcSEcCtD
Cefazolin—Convulsion—Carmustine—melanoma	0.000888	0.00385	CcSEcCtD
Cefazolin—Leukopenia—Temozolomide—melanoma	0.000887	0.00384	CcSEcCtD
Cefazolin—Neutropenia—Docetaxel—melanoma	0.000884	0.00383	CcSEcCtD
Cefazolin—Thrombocytopenia—Dactinomycin—melanoma	0.000875	0.00379	CcSEcCtD
Cefazolin—Convulsion—Temozolomide—melanoma	0.000858	0.00372	CcSEcCtD
Cefazolin—Anorexia—Dactinomycin—melanoma	0.000852	0.00369	CcSEcCtD
Cefazolin—Confusional state—Carmustine—melanoma	0.000844	0.00366	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000836	0.00362	CcSEcCtD
Cefazolin—Decreased appetite—Bleomycin—melanoma	0.000833	0.00361	CcSEcCtD
Cefazolin—Renal failure—Docetaxel—melanoma	0.000829	0.00359	CcSEcCtD
Cefazolin—Stomatitis—Docetaxel—melanoma	0.000822	0.00356	CcSEcCtD
Cefazolin—Pain—Bleomycin—melanoma	0.00082	0.00355	CcSEcCtD
Cefazolin—Thrombocytopenia—Carmustine—melanoma	0.000819	0.00355	CcSEcCtD
Cefazolin—Confusional state—Temozolomide—melanoma	0.000815	0.00353	CcSEcCtD
Cefazolin—Anaphylactic shock—Temozolomide—melanoma	0.000808	0.0035	CcSEcCtD
Cefazolin—Anorexia—Carmustine—melanoma	0.000797	0.00346	CcSEcCtD
Cefazolin—Thrombocytopenia—Temozolomide—melanoma	0.000792	0.00343	CcSEcCtD
Cefazolin—Feeling abnormal—Bleomycin—melanoma	0.00079	0.00342	CcSEcCtD
Cefazolin—Agranulocytosis—Docetaxel—melanoma	0.000787	0.00341	CcSEcCtD
Cefazolin—Hypotension—Carmustine—melanoma	0.000782	0.00339	CcSEcCtD
Cefazolin—Decreased appetite—Dactinomycin—melanoma	0.000777	0.00337	CcSEcCtD
Cefazolin—Fatigue—Dactinomycin—melanoma	0.000771	0.00334	CcSEcCtD
Cefazolin—Anorexia—Temozolomide—melanoma	0.000771	0.00334	CcSEcCtD
Cefazolin—Pain—Dactinomycin—melanoma	0.000764	0.00331	CcSEcCtD
Cefazolin—Urticaria—Bleomycin—melanoma	0.000761	0.0033	CcSEcCtD
Cefazolin—Haemoglobin—Docetaxel—melanoma	0.000761	0.0033	CcSEcCtD
Cefazolin—Body temperature increased—Bleomycin—melanoma	0.000758	0.00328	CcSEcCtD
Cefazolin—Hepatitis—Docetaxel—melanoma	0.000757	0.00328	CcSEcCtD
Cefazolin—Haemorrhage—Docetaxel—melanoma	0.000757	0.00328	CcSEcCtD
Cefazolin—Somnolence—Carmustine—melanoma	0.000744	0.00322	CcSEcCtD
Cefazolin—Feeling abnormal—Dactinomycin—melanoma	0.000737	0.00319	CcSEcCtD
Cefazolin—Gastrointestinal pain—Dactinomycin—melanoma	0.000731	0.00317	CcSEcCtD
Cefazolin—Decreased appetite—Carmustine—melanoma	0.000727	0.00315	CcSEcCtD
Cefazolin—Somnolence—Temozolomide—melanoma	0.000719	0.00311	CcSEcCtD
Cefazolin—Erythema multiforme—Docetaxel—melanoma	0.000715	0.0031	CcSEcCtD
Cefazolin—Pain—Carmustine—melanoma	0.000715	0.0031	CcSEcCtD
Cefazolin—Dyspepsia—Temozolomide—melanoma	0.000712	0.00308	CcSEcCtD
Cefazolin—Cefotetan—ALB—melanoma	0.000707	0.0448	CrCbGaD
Cefazolin—Abdominal pain—Dactinomycin—melanoma	0.000707	0.00306	CcSEcCtD
Cefazolin—Body temperature increased—Dactinomycin—melanoma	0.000707	0.00306	CcSEcCtD
Cefazolin—Hypersensitivity—Bleomycin—melanoma	0.000706	0.00306	CcSEcCtD
Cefazolin—Decreased appetite—Temozolomide—melanoma	0.000703	0.00305	CcSEcCtD
Cefazolin—Fatigue—Temozolomide—melanoma	0.000697	0.00302	CcSEcCtD
Cefazolin—ALB—lymph node—melanoma	0.000691	0.0159	CbGeAlD
Cefazolin—Pain—Temozolomide—melanoma	0.000691	0.003	CcSEcCtD
Cefazolin—Feeling abnormal—Carmustine—melanoma	0.000689	0.00299	CcSEcCtD
Cefazolin—Asthenia—Bleomycin—melanoma	0.000688	0.00298	CcSEcCtD
Cefazolin—Gastrointestinal pain—Carmustine—melanoma	0.000684	0.00296	CcSEcCtD
Cefazolin—Pruritus—Bleomycin—melanoma	0.000678	0.00294	CcSEcCtD
Cefazolin—ABCC4—lymph node—melanoma	0.000669	0.0154	CbGeAlD
Cefazolin—Feeling abnormal—Temozolomide—melanoma	0.000666	0.00289	CcSEcCtD
Cefazolin—Body temperature increased—Carmustine—melanoma	0.000661	0.00287	CcSEcCtD
Cefazolin—Abdominal pain—Carmustine—melanoma	0.000661	0.00287	CcSEcCtD
Cefazolin—Gastrointestinal pain—Temozolomide—melanoma	0.000661	0.00287	CcSEcCtD
Cefazolin—Hypersensitivity—Dactinomycin—melanoma	0.000659	0.00285	CcSEcCtD
Cefazolin—Urticaria—Temozolomide—melanoma	0.000642	0.00278	CcSEcCtD
Cefazolin—Asthenia—Dactinomycin—melanoma	0.000641	0.00278	CcSEcCtD
Cefazolin—Abdominal pain—Temozolomide—melanoma	0.000639	0.00277	CcSEcCtD
Cefazolin—Body temperature increased—Temozolomide—melanoma	0.000639	0.00277	CcSEcCtD
Cefazolin—Hypersensitivity—Carmustine—melanoma	0.000616	0.00267	CcSEcCtD
Cefazolin—Cefpiramide—ALB—melanoma	0.000615	0.039	CrCbGaD
Cefazolin—Diarrhoea—Dactinomycin—melanoma	0.000612	0.00265	CcSEcCtD
Cefazolin—Vomiting—Bleomycin—melanoma	0.000609	0.00264	CcSEcCtD
Cefazolin—Anaemia—Docetaxel—melanoma	0.000609	0.00264	CcSEcCtD
Cefazolin—Rash—Bleomycin—melanoma	0.000604	0.00262	CcSEcCtD
Cefazolin—Dermatitis—Bleomycin—melanoma	0.000604	0.00262	CcSEcCtD
Cefazolin—Asthenia—Carmustine—melanoma	0.0006	0.0026	CcSEcCtD
Cefazolin—Hypersensitivity—Temozolomide—melanoma	0.000596	0.00258	CcSEcCtD
Cefazolin—Syncope—Docetaxel—melanoma	0.000591	0.00256	CcSEcCtD
Cefazolin—Leukopenia—Docetaxel—melanoma	0.00059	0.00256	CcSEcCtD
Cefazolin—Asthenia—Temozolomide—melanoma	0.00058	0.00251	CcSEcCtD
Cefazolin—Loss of consciousness—Docetaxel—melanoma	0.000579	0.00251	CcSEcCtD
Cefazolin—Diarrhoea—Carmustine—melanoma	0.000572	0.00248	CcSEcCtD
Cefazolin—Pruritus—Temozolomide—melanoma	0.000572	0.00248	CcSEcCtD
Cefazolin—Convulsion—Docetaxel—melanoma	0.000571	0.00247	CcSEcCtD
Cefazolin—Nausea—Bleomycin—melanoma	0.000569	0.00247	CcSEcCtD
Cefazolin—Vomiting—Dactinomycin—melanoma	0.000568	0.00246	CcSEcCtD
Cefazolin—Rash—Dactinomycin—melanoma	0.000564	0.00244	CcSEcCtD
Cefazolin—Dizziness—Carmustine—melanoma	0.000553	0.0024	CcSEcCtD
Cefazolin—Diarrhoea—Temozolomide—melanoma	0.000553	0.0024	CcSEcCtD
Cefazolin—Confusional state—Docetaxel—melanoma	0.000542	0.00235	CcSEcCtD
Cefazolin—Anaphylactic shock—Docetaxel—melanoma	0.000538	0.00233	CcSEcCtD
Cefazolin—Cefonicid—ALB—melanoma	0.000536	0.034	CrCbGaD
Cefazolin—Dizziness—Temozolomide—melanoma	0.000535	0.00232	CcSEcCtD
Cefazolin—Vomiting—Carmustine—melanoma	0.000532	0.00231	CcSEcCtD
Cefazolin—Nausea—Dactinomycin—melanoma	0.000531	0.0023	CcSEcCtD
Cefazolin—Shock—Docetaxel—melanoma	0.000529	0.00229	CcSEcCtD
Cefazolin—Rash—Carmustine—melanoma	0.000527	0.00229	CcSEcCtD
Cefazolin—Dermatitis—Carmustine—melanoma	0.000527	0.00228	CcSEcCtD
Cefazolin—Thrombocytopenia—Docetaxel—melanoma	0.000526	0.00228	CcSEcCtD
Cefazolin—Headache—Carmustine—melanoma	0.000524	0.00227	CcSEcCtD
Cefazolin—Vomiting—Temozolomide—melanoma	0.000514	0.00223	CcSEcCtD
Cefazolin—Anorexia—Docetaxel—melanoma	0.000512	0.00222	CcSEcCtD
Cefazolin—Rash—Temozolomide—melanoma	0.00051	0.00221	CcSEcCtD
Cefazolin—Dermatitis—Temozolomide—melanoma	0.000509	0.00221	CcSEcCtD
Cefazolin—Headache—Temozolomide—melanoma	0.000506	0.00219	CcSEcCtD
Cefazolin—Hypotension—Docetaxel—melanoma	0.000502	0.00218	CcSEcCtD
Cefazolin—Nausea—Carmustine—melanoma	0.000497	0.00215	CcSEcCtD
Cefazolin—Nausea—Temozolomide—melanoma	0.00048	0.00208	CcSEcCtD
Cefazolin—Somnolence—Docetaxel—melanoma	0.000478	0.00207	CcSEcCtD
Cefazolin—Dyspepsia—Docetaxel—melanoma	0.000473	0.00205	CcSEcCtD
Cefazolin—Cefmetazole—ALB—melanoma	0.000472	0.0299	CrCbGaD
Cefazolin—Decreased appetite—Docetaxel—melanoma	0.000467	0.00203	CcSEcCtD
Cefazolin—Fatigue—Docetaxel—melanoma	0.000464	0.00201	CcSEcCtD
Cefazolin—Pain—Docetaxel—melanoma	0.00046	0.00199	CcSEcCtD
Cefazolin—Feeling abnormal—Docetaxel—melanoma	0.000443	0.00192	CcSEcCtD
Cefazolin—Gastrointestinal pain—Docetaxel—melanoma	0.00044	0.00191	CcSEcCtD
Cefazolin—Abdominal pain—Docetaxel—melanoma	0.000425	0.00184	CcSEcCtD
Cefazolin—Body temperature increased—Docetaxel—melanoma	0.000425	0.00184	CcSEcCtD
Cefazolin—Hypersensitivity—Docetaxel—melanoma	0.000396	0.00172	CcSEcCtD
Cefazolin—Asthenia—Docetaxel—melanoma	0.000386	0.00167	CcSEcCtD
Cefazolin—Pruritus—Docetaxel—melanoma	0.00038	0.00165	CcSEcCtD
Cefazolin—Diarrhoea—Docetaxel—melanoma	0.000368	0.00159	CcSEcCtD
Cefazolin—Dizziness—Docetaxel—melanoma	0.000356	0.00154	CcSEcCtD
Cefazolin—Vomiting—Docetaxel—melanoma	0.000342	0.00148	CcSEcCtD
Cefazolin—Rash—Docetaxel—melanoma	0.000339	0.00147	CcSEcCtD
Cefazolin—Dermatitis—Docetaxel—melanoma	0.000339	0.00147	CcSEcCtD
Cefazolin—Headache—Docetaxel—melanoma	0.000337	0.00146	CcSEcCtD
Cefazolin—Nausea—Docetaxel—melanoma	0.000319	0.00138	CcSEcCtD
Cefazolin—Cefoperazone—ALB—melanoma	0.000316	0.02	CrCbGaD
Cefazolin—Ceftriaxone—ALB—melanoma	0.000246	0.0156	CrCbGaD
Cefazolin—Cefalotin—ALB—melanoma	0.000215	0.0137	CrCbGaD
Cefazolin—Cephalexin—ALB—melanoma	0.000196	0.0124	CrCbGaD
Cefazolin—ABCC4—Hemostasis—RAC2—melanoma	0.000134	0.00164	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—VCAN—melanoma	0.000134	0.00164	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFC—melanoma	0.000132	0.00161	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ARL2—melanoma	0.000132	0.00161	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RHOB—melanoma	0.000132	0.0016	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—RAC1—melanoma	0.000129	0.00157	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IFNG—melanoma	0.000126	0.00154	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000121	0.00147	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RAC2—melanoma	0.000118	0.00144	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—FN1—melanoma	0.000116	0.00142	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SPARC—melanoma	0.000116	0.00141	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—F2R—melanoma	0.000116	0.00141	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFC—melanoma	0.000116	0.00141	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—FN1—melanoma	0.000114	0.00139	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—ALB—melanoma	0.000114	0.00138	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP17A1—melanoma	0.000113	0.00138	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—FN1—melanoma	0.000111	0.00135	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—EGF—melanoma	0.00011	0.00134	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—melanoma	0.000109	0.00133	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HSPA5—melanoma	0.000109	0.00132	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—CTNNB1—melanoma	0.000108	0.00132	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—EGF—melanoma	0.000108	0.00131	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—ICAM1—melanoma	0.000107	0.00131	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GNA11—melanoma	0.000107	0.0013	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—GAB2—melanoma	0.000106	0.00129	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—GNA11—melanoma	0.000106	0.00129	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—NFKB1—melanoma	0.000105	0.00128	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—EGF—melanoma	0.000105	0.00128	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—FASN—melanoma	0.000105	0.00128	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SLC5A5—melanoma	0.000103	0.00125	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IFNG—melanoma	0.000103	0.00125	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SPARC—melanoma	0.000102	0.00124	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—F2R—melanoma	0.000102	0.00124	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—IGF1—melanoma	0.000102	0.00124	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC15A2—melanoma	0.0001	0.00122	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HDAC2—melanoma	9.98e-05	0.00122	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—IGF1—melanoma	9.97e-05	0.00122	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GNAQ—melanoma	9.93e-05	0.00121	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CD44—melanoma	9.93e-05	0.00121	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—GNAQ—melanoma	9.86e-05	0.0012	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CD44—melanoma	9.86e-05	0.0012	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ITGA4—melanoma	9.86e-05	0.0012	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IFNB1—melanoma	9.79e-05	0.00119	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—melanoma	9.69e-05	0.00118	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC17A5—melanoma	9.63e-05	0.00117	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—melanoma	9.57e-05	0.00117	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IFNA1—melanoma	9.55e-05	0.00117	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—HSPA5—melanoma	9.53e-05	0.00116	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP1B1—melanoma	9.52e-05	0.00116	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—ALB—melanoma	9.45e-05	0.00115	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—GAB2—melanoma	9.31e-05	0.00114	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—GNA11—melanoma	9.31e-05	0.00114	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SYK—melanoma	9.27e-05	0.00113	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC5A5—melanoma	9.22e-05	0.00112	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ABCB1—melanoma	9.22e-05	0.00112	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	9.2e-05	0.00112	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL2—melanoma	9.12e-05	0.00111	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT3—melanoma	9.1e-05	0.00111	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ITGAV—melanoma	9.1e-05	0.00111	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IFNA2—melanoma	8.89e-05	0.00108	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC5A5—melanoma	8.84e-05	0.00108	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC6A11—melanoma	8.75e-05	0.00107	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—MYC—melanoma	8.73e-05	0.00107	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—GNAQ—melanoma	8.66e-05	0.00106	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—ALB—melanoma	8.66e-05	0.00106	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—NFKB1—melanoma	8.54e-05	0.00104	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—melanoma	8.35e-05	0.00102	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ITGB1—melanoma	8.27e-05	0.00101	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—TNF—melanoma	8.16e-05	0.000996	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IFNG—melanoma	8.15e-05	0.000994	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—BSG—melanoma	8.15e-05	0.000993	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SYK—melanoma	8.14e-05	0.000993	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT3—melanoma	7.99e-05	0.000975	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IFNA5—melanoma	7.89e-05	0.000962	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC5A5—melanoma	7.87e-05	0.00096	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ABCB1—melanoma	7.84e-05	0.000956	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—PTGS2—melanoma	7.82e-05	0.000953	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—melanoma	7.7e-05	0.000939	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CUBN—melanoma	7.68e-05	0.000936	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—IL2—melanoma	7.66e-05	0.000935	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FLNA—melanoma	7.66e-05	0.000934	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HGF—melanoma	7.56e-05	0.000922	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CSF2—melanoma	7.48e-05	0.000912	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—ALB—melanoma	7.22e-05	0.000881	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PRKCA—melanoma	7.22e-05	0.00088	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GPAM—melanoma	7.18e-05	0.000876	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PRKCA—melanoma	7.17e-05	0.000874	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ITGB3—melanoma	7.17e-05	0.000874	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ERCC2—melanoma	7.16e-05	0.000873	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ABCB1—melanoma	7.03e-05	0.000858	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CLU—melanoma	6.93e-05	0.000845	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	6.84e-05	0.000834	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—NFKB1—melanoma	6.78e-05	0.000827	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RHOB—melanoma	6.78e-05	0.000827	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACER3—melanoma	6.76e-05	0.000825	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ABCB1—melanoma	6.74e-05	0.000822	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—VEGFA—melanoma	6.64e-05	0.00081	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—RAC1—melanoma	6.64e-05	0.00081	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TNF—melanoma	6.64e-05	0.00081	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—HGF—melanoma	6.64e-05	0.000809	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—melanoma	6.59e-05	0.000803	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—CSF2—melanoma	6.56e-05	0.0008	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—melanoma	6.51e-05	0.000794	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MMP1—melanoma	6.43e-05	0.000784	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—melanoma	6.33e-05	0.000772	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CDK2—melanoma	6.31e-05	0.000769	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—ITGB3—melanoma	6.29e-05	0.000767	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PRKCA—melanoma	6.29e-05	0.000767	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UGT2B10—melanoma	6.19e-05	0.000754	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—MAPK3—melanoma	6.16e-05	0.000751	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	6.11e-05	0.000745	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RAC2—melanoma	6.07e-05	0.000741	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFC—melanoma	5.98e-05	0.000729	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	5.87e-05	0.000716	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—FN1—melanoma	5.87e-05	0.000715	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—MAPK1—melanoma	5.86e-05	0.000715	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—melanoma	5.86e-05	0.000714	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RAC1—melanoma	5.83e-05	0.000711	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS2—melanoma	5.8e-05	0.000707	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ALB—melanoma	5.77e-05	0.000703	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HS3ST5—melanoma	5.75e-05	0.000701	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CG—melanoma	5.65e-05	0.000689	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CG—melanoma	5.61e-05	0.000685	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—EGF—melanoma	5.55e-05	0.000677	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPARG—melanoma	5.46e-05	0.000665	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—melanoma	5.36e-05	0.000654	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—melanoma	5.28e-05	0.000643	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SPARC—melanoma	5.25e-05	0.00064	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—F2R—melanoma	5.25e-05	0.00064	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—FN1—melanoma	5.15e-05	0.000628	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IGF1—melanoma	5.14e-05	0.000627	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—melanoma	5.09e-05	0.00062	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CD—melanoma	4.97e-05	0.000606	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CD—melanoma	4.94e-05	0.000602	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CG—melanoma	4.93e-05	0.000601	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HSPA5—melanoma	4.91e-05	0.000599	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALB—melanoma	4.91e-05	0.000598	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ALB—melanoma	4.87e-05	0.000594	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—EGF—melanoma	4.87e-05	0.000594	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GNA11—melanoma	4.8e-05	0.000586	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GAB2—melanoma	4.8e-05	0.000586	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.63e-05	0.000564	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HDAC2—melanoma	4.51e-05	0.00055	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IGF1—melanoma	4.51e-05	0.00055	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GNAQ—melanoma	4.46e-05	0.000544	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITGA4—melanoma	4.46e-05	0.000544	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CD44—melanoma	4.46e-05	0.000544	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IFNB1—melanoma	4.43e-05	0.00054	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ALB—melanoma	4.4e-05	0.000536	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PLCB4—melanoma	4.36e-05	0.000531	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CD—melanoma	4.33e-05	0.000528	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CB—melanoma	4.33e-05	0.000528	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IFNA1—melanoma	4.32e-05	0.000527	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CB—melanoma	4.3e-05	0.000525	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS2—melanoma	4.29e-05	0.000523	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—FASN—melanoma	4.28e-05	0.000522	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—melanoma	4.26e-05	0.000519	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ALB—melanoma	4.22e-05	0.000514	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SYK—melanoma	4.2e-05	0.000512	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT1—melanoma	4.16e-05	0.000507	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITGAV—melanoma	4.12e-05	0.000502	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT3—melanoma	4.12e-05	0.000502	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC6A11—melanoma	4.1e-05	0.0005	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIP4K2A—melanoma	4.1e-05	0.0005	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IFNA2—melanoma	4.02e-05	0.000491	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	4e-05	0.000488	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTAP—melanoma	3.99e-05	0.000486	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IL2—melanoma	3.95e-05	0.000482	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.9e-05	0.000475	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	3.78e-05	0.000461	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTEN—melanoma	3.74e-05	0.000456	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITGB1—melanoma	3.74e-05	0.000456	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	3.67e-05	0.000448	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PHGDH—melanoma	3.55e-05	0.000433	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LUM—melanoma	3.55e-05	0.000433	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HPSE—melanoma	3.48e-05	0.000425	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	3.47e-05	0.000423	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HGF—melanoma	3.42e-05	0.000417	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CUBN—melanoma	3.42e-05	0.000417	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CSF2—melanoma	3.38e-05	0.000413	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—melanoma	3.36e-05	0.000409	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NRAS—melanoma	3.32e-05	0.000404	CbGpPWpGaD
Cefazolin—ALB—Metabolism—BSG—melanoma	3.3e-05	0.000403	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SDHD—melanoma	3.3e-05	0.000403	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CSPG4—melanoma	3.3e-05	0.000403	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITGB3—melanoma	3.24e-05	0.000395	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKCA—melanoma	3.24e-05	0.000395	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPAM—melanoma	3.2e-05	0.00039	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MAPK3—melanoma	3.18e-05	0.000387	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	3.05e-05	0.000372	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MAPK1—melanoma	3.02e-05	0.000369	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RAC1—melanoma	3.01e-05	0.000367	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	2.95e-05	0.000359	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MMP1—melanoma	2.91e-05	0.000355	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CDK2—melanoma	2.86e-05	0.000348	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—KRAS—melanoma	2.85e-05	0.000348	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	2.79e-05	0.00034	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PLA2G6—melanoma	2.72e-05	0.000332	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FN1—melanoma	2.65e-05	0.000324	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	2.65e-05	0.000324	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CA—melanoma	2.64e-05	0.000322	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS2—melanoma	2.62e-05	0.00032	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CA—melanoma	2.62e-05	0.00032	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CG—melanoma	2.54e-05	0.00031	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—melanoma	2.54e-05	0.000309	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—EGF—melanoma	2.51e-05	0.000306	CbGpPWpGaD
Cefazolin—ALB—Metabolism—VCAN—melanoma	2.44e-05	0.000298	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HRAS—melanoma	2.43e-05	0.000296	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF1—melanoma	2.33e-05	0.000284	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.31e-05	0.000282	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	2.3e-05	0.000281	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CD—melanoma	2.23e-05	0.000272	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.23e-05	0.000272	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKT1—melanoma	2.16e-05	0.000263	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT1—melanoma	2.14e-05	0.000261	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP17A1—melanoma	2.06e-05	0.000251	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.03e-05	0.000248	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GNA11—melanoma	1.95e-05	0.000237	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CB—melanoma	1.95e-05	0.000237	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FASN—melanoma	1.91e-05	0.000232	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.88e-05	0.000229	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC5A5—melanoma	1.87e-05	0.000229	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GNAQ—melanoma	1.81e-05	0.000221	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CD44—melanoma	1.81e-05	0.000221	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IL2—melanoma	1.79e-05	0.000218	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.77e-05	0.000216	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.76e-05	0.000214	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1B1—melanoma	1.74e-05	0.000212	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.53e-05	0.000187	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—melanoma	1.52e-05	0.000185	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NRAS—melanoma	1.5e-05	0.000183	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MAPK3—melanoma	1.44e-05	0.000175	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCB1—melanoma	1.43e-05	0.000174	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MAPK1—melanoma	1.37e-05	0.000167	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PRKCA—melanoma	1.31e-05	0.00016	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ERCC2—melanoma	1.3e-05	0.000159	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—KRAS—melanoma	1.29e-05	0.000158	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CA—melanoma	1.19e-05	0.000145	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—melanoma	1.15e-05	0.00014	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HRAS—melanoma	1.1e-05	0.000134	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.08e-05	0.000132	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CG—melanoma	1.03e-05	0.000126	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARG—melanoma	9.94e-06	0.000121	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT1—melanoma	9.69e-06	0.000118	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CD—melanoma	9.05e-06	0.00011	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CB—melanoma	7.89e-06	9.62e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS2—melanoma	7.82e-06	9.54e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTEN—melanoma	6.82e-06	8.32e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CA—melanoma	4.81e-06	5.87e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKT1—melanoma	3.93e-06	4.79e-05	CbGpPWpGaD
